Global Central Nervous System (CNS) Therapeutic Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Central Nervous System (CNS) Therapeutic market size was valued at US$ 72530 million in 2023. With growing demand in downstream market, the Central Nervous System (CNS) Therapeutic is forecast to a readjusted size of US$ 92100 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Central Nervous System (CNS) Therapeutic market. Central Nervous System (CNS) Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Central Nervous System (CNS) Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Central Nervous System (CNS) Therapeutic market.
A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Central Nervous System (CNS) Therapeutic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Central Nervous System (CNS) Therapeutic market. It may include historical data, market segmentation by Type (e.g., Neurovascular, Trauma), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Central Nervous System (CNS) Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Central Nervous System (CNS) Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Central Nervous System (CNS) Therapeutic industry. This include advancements in Central Nervous System (CNS) Therapeutic technology, Central Nervous System (CNS) Therapeutic new entrants, Central Nervous System (CNS) Therapeutic new investment, and other innovations that are shaping the future of Central Nervous System (CNS) Therapeutic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Central Nervous System (CNS) Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Central Nervous System (CNS) Therapeutic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Central Nervous System (CNS) Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Central Nervous System (CNS) Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Central Nervous System (CNS) Therapeutic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Central Nervous System (CNS) Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Central Nervous System (CNS) Therapeutic market.
Market Segmentation:
Central Nervous System (CNS) Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Central Nervous System (CNS) Therapeutic market size was valued at US$ 72530 million in 2023. With growing demand in downstream market, the Central Nervous System (CNS) Therapeutic is forecast to a readjusted size of US$ 92100 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Central Nervous System (CNS) Therapeutic market. Central Nervous System (CNS) Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Central Nervous System (CNS) Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Central Nervous System (CNS) Therapeutic market.
A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Central Nervous System (CNS) Therapeutic market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Central Nervous System (CNS) Therapeutic market. It may include historical data, market segmentation by Type (e.g., Neurovascular, Trauma), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Central Nervous System (CNS) Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Central Nervous System (CNS) Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Central Nervous System (CNS) Therapeutic industry. This include advancements in Central Nervous System (CNS) Therapeutic technology, Central Nervous System (CNS) Therapeutic new entrants, Central Nervous System (CNS) Therapeutic new investment, and other innovations that are shaping the future of Central Nervous System (CNS) Therapeutic.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Central Nervous System (CNS) Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Central Nervous System (CNS) Therapeutic product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Central Nervous System (CNS) Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Central Nervous System (CNS) Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Central Nervous System (CNS) Therapeutic market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Central Nervous System (CNS) Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Central Nervous System (CNS) Therapeutic market.
Market Segmentation:
Central Nervous System (CNS) Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Neurovascular
- Trauma
- Mental Health
- Degenerative Disorder
- Infections
- Cancer
- Clinical Application
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Biogen
- Johnson & Johnson
- Eli Lilly
- Otsuka America Pharmaceutical
- Merck
- Astrazeneca
- Novartis
- Teva Pharmaceutical Industries
- Takeda
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System (CNS) Therapeutic Market Size 2019-2030
2.1.2 Central Nervous System (CNS) Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Central Nervous System (CNS) Therapeutic Segment by Type
2.2.1 Neurovascular
2.2.2 Trauma
2.2.3 Mental Health
2.2.4 Degenerative Disorder
2.2.5 Infections
2.2.6 Cancer
2.3 Central Nervous System (CNS) Therapeutic Market Size by Type
2.3.1 Central Nervous System (CNS) Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Central Nervous System (CNS) Therapeutic Segment by Application
2.4.1 Clinical Application
2.4.2 Others
2.5 Central Nervous System (CNS) Therapeutic Market Size by Application
2.5.1 Central Nervous System (CNS) Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
3 CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Central Nervous System (CNS) Therapeutic Market Size Market Share by Players
3.1.1 Global Central Nervous System (CNS) Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Central Nervous System (CNS) Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC BY REGIONS
4.1 Central Nervous System (CNS) Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
4.3 APAC Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
4.4 Europe Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)
5.2 Americas Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
5.3 Americas Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024)
6.2 APAC Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
6.3 APAC Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Central Nervous System (CNS) Therapeutic by Country (2019-2024)
7.2 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System (CNS) Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET FORECAST
10.1 Global Central Nervous System (CNS) Therapeutic Forecast by Regions (2025-2030)
10.1.1 Global Central Nervous System (CNS) Therapeutic Forecast by Regions (2025-2030)
10.1.2 Americas Central Nervous System (CNS) Therapeutic Forecast
10.1.3 APAC Central Nervous System (CNS) Therapeutic Forecast
10.1.4 Europe Central Nervous System (CNS) Therapeutic Forecast
10.1.5 Middle East & Africa Central Nervous System (CNS) Therapeutic Forecast
10.2 Americas Central Nervous System (CNS) Therapeutic Forecast by Country (2025-2030)
10.2.1 United States Central Nervous System (CNS) Therapeutic Market Forecast
10.2.2 Canada Central Nervous System (CNS) Therapeutic Market Forecast
10.2.3 Mexico Central Nervous System (CNS) Therapeutic Market Forecast
10.2.4 Brazil Central Nervous System (CNS) Therapeutic Market Forecast
10.3 APAC Central Nervous System (CNS) Therapeutic Forecast by Region (2025-2030)
10.3.1 China Central Nervous System (CNS) Therapeutic Market Forecast
10.3.2 Japan Central Nervous System (CNS) Therapeutic Market Forecast
10.3.3 Korea Central Nervous System (CNS) Therapeutic Market Forecast
10.3.4 Southeast Asia Central Nervous System (CNS) Therapeutic Market Forecast
10.3.5 India Central Nervous System (CNS) Therapeutic Market Forecast
10.3.6 Australia Central Nervous System (CNS) Therapeutic Market Forecast
10.4 Europe Central Nervous System (CNS) Therapeutic Forecast by Country (2025-2030)
10.4.1 Germany Central Nervous System (CNS) Therapeutic Market Forecast
10.4.2 France Central Nervous System (CNS) Therapeutic Market Forecast
10.4.3 UK Central Nervous System (CNS) Therapeutic Market Forecast
10.4.4 Italy Central Nervous System (CNS) Therapeutic Market Forecast
10.4.5 Russia Central Nervous System (CNS) Therapeutic Market Forecast
10.5 Middle East & Africa Central Nervous System (CNS) Therapeutic Forecast by Region (2025-2030)
10.5.1 Egypt Central Nervous System (CNS) Therapeutic Market Forecast
10.5.2 South Africa Central Nervous System (CNS) Therapeutic Market Forecast
10.5.3 Israel Central Nervous System (CNS) Therapeutic Market Forecast
10.5.4 Turkey Central Nervous System (CNS) Therapeutic Market Forecast
10.5.5 GCC Countries Central Nervous System (CNS) Therapeutic Market Forecast
10.6 Global Central Nervous System (CNS) Therapeutic Forecast by Type (2025-2030)
10.7 Global Central Nervous System (CNS) Therapeutic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Central Nervous System (CNS) Therapeutic Product Offered
11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Central Nervous System (CNS) Therapeutic Product Offered
11.2.3 Biogen Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Central Nervous System (CNS) Therapeutic Product Offered
11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Central Nervous System (CNS) Therapeutic Product Offered
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Otsuka America Pharmaceutical
11.5.1 Otsuka America Pharmaceutical Company Information
11.5.2 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product Offered
11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Otsuka America Pharmaceutical Main Business Overview
11.5.5 Otsuka America Pharmaceutical Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Central Nervous System (CNS) Therapeutic Product Offered
11.6.3 Merck Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Astrazeneca
11.7.1 Astrazeneca Company Information
11.7.2 Astrazeneca Central Nervous System (CNS) Therapeutic Product Offered
11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Astrazeneca Main Business Overview
11.7.5 Astrazeneca Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Central Nervous System (CNS) Therapeutic Product Offered
11.8.3 Novartis Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Information
11.9.2 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product Offered
11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Industries Main Business Overview
11.9.5 Teva Pharmaceutical Industries Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Central Nervous System (CNS) Therapeutic Product Offered
11.10.3 Takeda Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Central Nervous System (CNS) Therapeutic Market Size 2019-2030
2.1.2 Central Nervous System (CNS) Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Central Nervous System (CNS) Therapeutic Segment by Type
2.2.1 Neurovascular
2.2.2 Trauma
2.2.3 Mental Health
2.2.4 Degenerative Disorder
2.2.5 Infections
2.2.6 Cancer
2.3 Central Nervous System (CNS) Therapeutic Market Size by Type
2.3.1 Central Nervous System (CNS) Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Central Nervous System (CNS) Therapeutic Segment by Application
2.4.1 Clinical Application
2.4.2 Others
2.5 Central Nervous System (CNS) Therapeutic Market Size by Application
2.5.1 Central Nervous System (CNS) Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
3 CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Central Nervous System (CNS) Therapeutic Market Size Market Share by Players
3.1.1 Global Central Nervous System (CNS) Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Central Nervous System (CNS) Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC BY REGIONS
4.1 Central Nervous System (CNS) Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
4.3 APAC Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
4.4 Europe Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)
5.2 Americas Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
5.3 Americas Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024)
6.2 APAC Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
6.3 APAC Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Central Nervous System (CNS) Therapeutic by Country (2019-2024)
7.2 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Central Nervous System (CNS) Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET FORECAST
10.1 Global Central Nervous System (CNS) Therapeutic Forecast by Regions (2025-2030)
10.1.1 Global Central Nervous System (CNS) Therapeutic Forecast by Regions (2025-2030)
10.1.2 Americas Central Nervous System (CNS) Therapeutic Forecast
10.1.3 APAC Central Nervous System (CNS) Therapeutic Forecast
10.1.4 Europe Central Nervous System (CNS) Therapeutic Forecast
10.1.5 Middle East & Africa Central Nervous System (CNS) Therapeutic Forecast
10.2 Americas Central Nervous System (CNS) Therapeutic Forecast by Country (2025-2030)
10.2.1 United States Central Nervous System (CNS) Therapeutic Market Forecast
10.2.2 Canada Central Nervous System (CNS) Therapeutic Market Forecast
10.2.3 Mexico Central Nervous System (CNS) Therapeutic Market Forecast
10.2.4 Brazil Central Nervous System (CNS) Therapeutic Market Forecast
10.3 APAC Central Nervous System (CNS) Therapeutic Forecast by Region (2025-2030)
10.3.1 China Central Nervous System (CNS) Therapeutic Market Forecast
10.3.2 Japan Central Nervous System (CNS) Therapeutic Market Forecast
10.3.3 Korea Central Nervous System (CNS) Therapeutic Market Forecast
10.3.4 Southeast Asia Central Nervous System (CNS) Therapeutic Market Forecast
10.3.5 India Central Nervous System (CNS) Therapeutic Market Forecast
10.3.6 Australia Central Nervous System (CNS) Therapeutic Market Forecast
10.4 Europe Central Nervous System (CNS) Therapeutic Forecast by Country (2025-2030)
10.4.1 Germany Central Nervous System (CNS) Therapeutic Market Forecast
10.4.2 France Central Nervous System (CNS) Therapeutic Market Forecast
10.4.3 UK Central Nervous System (CNS) Therapeutic Market Forecast
10.4.4 Italy Central Nervous System (CNS) Therapeutic Market Forecast
10.4.5 Russia Central Nervous System (CNS) Therapeutic Market Forecast
10.5 Middle East & Africa Central Nervous System (CNS) Therapeutic Forecast by Region (2025-2030)
10.5.1 Egypt Central Nervous System (CNS) Therapeutic Market Forecast
10.5.2 South Africa Central Nervous System (CNS) Therapeutic Market Forecast
10.5.3 Israel Central Nervous System (CNS) Therapeutic Market Forecast
10.5.4 Turkey Central Nervous System (CNS) Therapeutic Market Forecast
10.5.5 GCC Countries Central Nervous System (CNS) Therapeutic Market Forecast
10.6 Global Central Nervous System (CNS) Therapeutic Forecast by Type (2025-2030)
10.7 Global Central Nervous System (CNS) Therapeutic Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Central Nervous System (CNS) Therapeutic Product Offered
11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Central Nervous System (CNS) Therapeutic Product Offered
11.2.3 Biogen Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Central Nervous System (CNS) Therapeutic Product Offered
11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Main Business Overview
11.3.5 Johnson & Johnson Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Central Nervous System (CNS) Therapeutic Product Offered
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Otsuka America Pharmaceutical
11.5.1 Otsuka America Pharmaceutical Company Information
11.5.2 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product Offered
11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Otsuka America Pharmaceutical Main Business Overview
11.5.5 Otsuka America Pharmaceutical Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Central Nervous System (CNS) Therapeutic Product Offered
11.6.3 Merck Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Astrazeneca
11.7.1 Astrazeneca Company Information
11.7.2 Astrazeneca Central Nervous System (CNS) Therapeutic Product Offered
11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Astrazeneca Main Business Overview
11.7.5 Astrazeneca Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Central Nervous System (CNS) Therapeutic Product Offered
11.8.3 Novartis Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Information
11.9.2 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product Offered
11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Pharmaceutical Industries Main Business Overview
11.9.5 Teva Pharmaceutical Industries Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Central Nervous System (CNS) Therapeutic Product Offered
11.10.3 Takeda Central Nervous System (CNS) Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Central Nervous System (CNS) Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Neurovascular
Table 3. Major Players of Trauma
Table 4. Major Players of Mental Health
Table 5. Major Players of Degenerative Disorder
Table 6. Major Players of Infections
Table 7. Major Players of Cancer
Table 8. Central Nervous System (CNS) Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 11. Central Nervous System (CNS) Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 14. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Player (2019-2024)
Table 16. Central Nervous System (CNS) Therapeutic Key Players Head office and Products Offered
Table 17. Central Nervous System (CNS) Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Central Nervous System (CNS) Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Regions (2019-2024)
Table 22. Global Central Nervous System (CNS) Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Central Nervous System (CNS) Therapeutic Market Size Market Share by Country (2019-2024)
Table 26. Americas Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 28. Americas Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 30. APAC Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Region (2019-2024)
Table 32. APAC Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 34. APAC Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 36. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Country (2019-2024)
Table 38. Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 40. Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Central Nervous System (CNS) Therapeutic
Table 49. Key Market Challenges & Risks of Central Nervous System (CNS) Therapeutic
Table 50. Key Industry Trends of Central Nervous System (CNS) Therapeutic
Table 51. Global Central Nervous System (CNS) Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Central Nervous System (CNS) Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Central Nervous System (CNS) Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Central Nervous System (CNS) Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Pfizer Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 56. Pfizer Central Nervous System (CNS) Therapeutic Product Offered
Table 57. Pfizer Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Biogen Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 61. Biogen Central Nervous System (CNS) Therapeutic Product Offered
Table 62. Biogen Main Business
Table 63. Biogen Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Biogen Latest Developments
Table 65. Johnson & Johnson Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 66. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product Offered
Table 67. Johnson & Johnson Main Business
Table 68. Johnson & Johnson Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Johnson & Johnson Latest Developments
Table 70. Eli Lilly Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 71. Eli Lilly Central Nervous System (CNS) Therapeutic Product Offered
Table 72. Eli Lilly Main Business
Table 73. Eli Lilly Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Eli Lilly Latest Developments
Table 75. Otsuka America Pharmaceutical Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 76. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product Offered
Table 77. Otsuka America Pharmaceutical Main Business
Table 78. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Otsuka America Pharmaceutical Latest Developments
Table 80. Merck Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 81. Merck Central Nervous System (CNS) Therapeutic Product Offered
Table 82. Merck Main Business
Table 83. Merck Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Merck Latest Developments
Table 85. Astrazeneca Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 86. Astrazeneca Central Nervous System (CNS) Therapeutic Product Offered
Table 87. Astrazeneca Main Business
Table 88. Astrazeneca Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Astrazeneca Latest Developments
Table 90. Novartis Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 91. Novartis Central Nervous System (CNS) Therapeutic Product Offered
Table 92. Novartis Main Business
Table 93. Novartis Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Novartis Latest Developments
Table 95. Teva Pharmaceutical Industries Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 96. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product Offered
Table 97. Teva Pharmaceutical Industries Main Business
Table 98. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Teva Pharmaceutical Industries Latest Developments
Table 100. Takeda Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 101. Takeda Central Nervous System (CNS) Therapeutic Product Offered
Table 102. Takeda Main Business
Table 103. Takeda Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Takeda Latest Developments
Table 1. Central Nervous System (CNS) Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Neurovascular
Table 3. Major Players of Trauma
Table 4. Major Players of Mental Health
Table 5. Major Players of Degenerative Disorder
Table 6. Major Players of Infections
Table 7. Major Players of Cancer
Table 8. Central Nervous System (CNS) Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 11. Central Nervous System (CNS) Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 14. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Player (2019-2024)
Table 16. Central Nervous System (CNS) Therapeutic Key Players Head office and Products Offered
Table 17. Central Nervous System (CNS) Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Central Nervous System (CNS) Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Regions (2019-2024)
Table 22. Global Central Nervous System (CNS) Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Central Nervous System (CNS) Therapeutic Market Size Market Share by Country (2019-2024)
Table 26. Americas Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 28. Americas Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 30. APAC Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Region (2019-2024)
Table 32. APAC Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 34. APAC Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 36. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Country (2019-2024)
Table 38. Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 40. Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Central Nervous System (CNS) Therapeutic
Table 49. Key Market Challenges & Risks of Central Nervous System (CNS) Therapeutic
Table 50. Key Industry Trends of Central Nervous System (CNS) Therapeutic
Table 51. Global Central Nervous System (CNS) Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Central Nervous System (CNS) Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Central Nervous System (CNS) Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Central Nervous System (CNS) Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Pfizer Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 56. Pfizer Central Nervous System (CNS) Therapeutic Product Offered
Table 57. Pfizer Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Biogen Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 61. Biogen Central Nervous System (CNS) Therapeutic Product Offered
Table 62. Biogen Main Business
Table 63. Biogen Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Biogen Latest Developments
Table 65. Johnson & Johnson Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 66. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product Offered
Table 67. Johnson & Johnson Main Business
Table 68. Johnson & Johnson Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Johnson & Johnson Latest Developments
Table 70. Eli Lilly Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 71. Eli Lilly Central Nervous System (CNS) Therapeutic Product Offered
Table 72. Eli Lilly Main Business
Table 73. Eli Lilly Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Eli Lilly Latest Developments
Table 75. Otsuka America Pharmaceutical Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 76. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product Offered
Table 77. Otsuka America Pharmaceutical Main Business
Table 78. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Otsuka America Pharmaceutical Latest Developments
Table 80. Merck Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 81. Merck Central Nervous System (CNS) Therapeutic Product Offered
Table 82. Merck Main Business
Table 83. Merck Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Merck Latest Developments
Table 85. Astrazeneca Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 86. Astrazeneca Central Nervous System (CNS) Therapeutic Product Offered
Table 87. Astrazeneca Main Business
Table 88. Astrazeneca Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Astrazeneca Latest Developments
Table 90. Novartis Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 91. Novartis Central Nervous System (CNS) Therapeutic Product Offered
Table 92. Novartis Main Business
Table 93. Novartis Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Novartis Latest Developments
Table 95. Teva Pharmaceutical Industries Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 96. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product Offered
Table 97. Teva Pharmaceutical Industries Main Business
Table 98. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Teva Pharmaceutical Industries Latest Developments
Table 100. Takeda Details, Company Type, Central Nervous System (CNS) Therapeutic Area Served and Its Competitors
Table 101. Takeda Central Nervous System (CNS) Therapeutic Product Offered
Table 102. Takeda Main Business
Table 103. Takeda Central Nervous System (CNS) Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Takeda Latest Developments
LIST OF FIGURES
Figure 1. Central Nervous System (CNS) Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Central Nervous System (CNS) Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Central Nervous System (CNS) Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. Central Nervous System (CNS) Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Type in 2023
Figure 10. Central Nervous System (CNS) Therapeutic in Clinical Application
Figure 11. Global Central Nervous System (CNS) Therapeutic Market: Clinical Application (2019-2024) & ($ Millions)
Figure 12. Central Nervous System (CNS) Therapeutic in Others
Figure 13. Global Central Nervous System (CNS) Therapeutic Market: Others (2019-2024) & ($ Millions)
Figure 14. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Application in 2023
Figure 15. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Player in 2023
Figure 16. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 18. APAC Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 19. Europe Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 21. Americas Central Nervous System (CNS) Therapeutic Value Market Share by Country in 2023
Figure 22. United States Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Region in 2023
Figure 27. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Type in 2023
Figure 28. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Application in 2023
Figure 29. China Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Country in 2023
Figure 36. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Figure 37. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Figure 38. Germany Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 52. APAC Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 53. Europe Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 55. United States Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 56. Canada Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. China Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Japan Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. Korea Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. India Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Australia Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. Germany Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. France Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. UK Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. Italy Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. Russia Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. Spain Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. Israel Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. Global Central Nervous System (CNS) Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Central Nervous System (CNS) Therapeutic Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Central Nervous System (CNS) Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Central Nervous System (CNS) Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Central Nervous System (CNS) Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. Central Nervous System (CNS) Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Type in 2023
Figure 10. Central Nervous System (CNS) Therapeutic in Clinical Application
Figure 11. Global Central Nervous System (CNS) Therapeutic Market: Clinical Application (2019-2024) & ($ Millions)
Figure 12. Central Nervous System (CNS) Therapeutic in Others
Figure 13. Global Central Nervous System (CNS) Therapeutic Market: Others (2019-2024) & ($ Millions)
Figure 14. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Application in 2023
Figure 15. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Player in 2023
Figure 16. Global Central Nervous System (CNS) Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 18. APAC Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 19. Europe Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size 2019-2024 ($ Millions)
Figure 21. Americas Central Nervous System (CNS) Therapeutic Value Market Share by Country in 2023
Figure 22. United States Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Region in 2023
Figure 27. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Type in 2023
Figure 28. APAC Central Nervous System (CNS) Therapeutic Market Size Market Share by Application in 2023
Figure 29. China Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Country in 2023
Figure 36. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Figure 37. Europe Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Figure 38. Germany Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Central Nervous System (CNS) Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 52. APAC Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 53. Europe Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 55. United States Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 56. Canada Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. China Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Japan Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. Korea Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. India Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Australia Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. Germany Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. France Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. UK Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. Italy Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. Russia Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. Spain Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. Israel Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Central Nervous System (CNS) Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. Global Central Nervous System (CNS) Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Central Nervous System (CNS) Therapeutic Market Size Market Share Forecast by Application (2025-2030)
